ZINZANI, PIER LUIGI
ZINZANI, PIER LUIGI
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
P. L. Zinzani; ZINZANI L; [Zinzani PL]; P. ZINZANI; ZINZANI P; ZINZANI P.L.
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas
2025 Kim, Won Seog; Shortt, Jake; Zinzani, Pier Luigi; Mikhailova, Natalia; Radeski, Dejan; Ribrag, Vincent; Domingo Domenech, Eva; Sawas, Ahmed; Alexis, Karenza; Emig, Michael; Elbadri, Riham; Hajela, Pallavi; Ravenstijn, Paulien; Pinto, Sheena; Garcia, Linta; Overesch, Andre; Pietzko, Kerstin; Horwitz, Steven
Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy
2025 Kuruvilla, John; Armand, Philippe; Herrera, Alex F.; Ribrag, Vincent; Thieblemont, Catherine; von Tresckow, Bastian; Wang, Guoqing; Marinello, Patricia; Chakraborty, Samhita; Orlowski, Robert; Zinzani, Pier Luigi
Assessing the economic burden of Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL)
2025 Scortichini, Matteo; Paoletti, Martina; Ragonese, Angela; Cuneo, Antonio; Vignetti, Marco; Zinzani, Pier Luigi
Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study
2025 Stella, Federico; Chiappella, Annalisa; Magni, Martina; Bonifazi, Francesca; De Philippis, Chiara; Musso, Maurizio; Cutini, Ilaria; Ljevar, Silva; Barbui, Anna Maria; Farina, Mirko; Martino, Massimo; Massaia, Massimo; Grillo, Giovanni; Angelillo, Piera; Botto, Barbara; Patriarca, Francesca; Krampera, Mauro; Arcaini, Luca; Tisi, Maria Chiara; Zinzani, Pier Luigi; Sorà, Federica; Bramanti, Stefania; Pennisi, Martina; Carniti, Cristiana; Corradini, Paolo
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210
2025 Bertuzzi, Clara; Righi, Simona; Motta, Giovanna; Rossi, Maura; Carella, Matteo; Gabrielli, Giulia; Facchini, Elena; Baldassarre, Maurizio; Prete, Arcangelo; Zinzani, Pier Luigi; Mascolo, Massimo; Agostinelli, Claudio; Sabattini, Elena
Covalent Bruton tyrosine kinase inhibitors across generations: A focus on zanubrutinib
2025 Broccoli, Alessandro; Del Re, Marzia; Danesi, Romano; Zinzani, Pier Luigi
Cutaneous T-cell lymphomas: a real-life experience of anticipated use of mogamulizumab in Italy
2025 Ardigò, Marco; Flenghi, Leonardo; Ibatici, Adalberto; Massone, Cesare; Quaglino, Pietro; Teoli, Miriam; Toldo, Chandrakala; Perrone, Tommasina; Tucci, Alessandra; Caccavale, Stefano; Zinzani, Pier L.
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
2025 Ribrag, Vincent; Bron, Dominique; Rymkiewicz, Grzegorz; Hoelzer, Dieter; Jørgensen, Judit; de Armas-Castellano, Aythami; Trujillo-Martín, Maria; Fenaux, Pierre; Malcovati, Luca; Bolaños, Natacha; Ribera, Josep-Maria; Herbaux, Charles; Sarkozy, Clémentine; Zinzani, Pier Luigi; Walewski, Jan; Chamuleau, Martine E D
Different definitions in intention-to-treat analysis for chimeric antigen receptor T-cell therapy depend on research scope
2025 Argnani, Lisa; Casadei, Beatrice; Zinzani, Pier Luigi
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma
2025 Mazzoni, Camilla; Argnani, Lisa; Casadei, Beatrice; Broccoli, Alessandro; Gabrielli, Giulia; Fabbri, Nicole; Gugliotta, Gabriele; Pellegrini, Cinzia; Carella, Matteo; Bagnato, Gianmarco; Gentilini, Marianna; Morigi, Alice; Maglio, Pierluca; Cantelli, Martina; Stefoni, Vittorio; Zinzani, PIER LUIGI
Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism
2025 Zengarini, Corrado; Mussi, Martina; Robuffo, Silva; Bagnato, Giammarco; Pellegrini, Cinzia; Zinzani, Pier L; Piraccini, Bianca M; Pileri, Alessandro
Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective study
2025 Chaturvedi, Shalini; Weispfenning, Anke; Descamps, Tine; Bellinvia, Sara; Bauer, David; Du, Rong; Lunt, Teresa; Soler, Lidia Mongay; Childs, Barrett H.; Zinzani, Pier Luigi
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice
2025 Pellegrini, Cinzia; Casadei, Beatrice; Broccoli, Alessandro; Cantelli, Martina; Gugliotta, Gabriele; Gentilini, Marianna; Carella, Matteo; Stefoni, Vittorio; Fabbri, Nicole; Gabrielli, Giulia; Argnani, Lisa; Mazzoni, Camilla; Maglio, Pierluca; Bagnato, Gianmarco; Zinzani, Pier Luigi
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
2025 Han, Jessy Xinyi; Koh, Min Jung; Boussi, Leora; Sorial, Mark; Mccabe, Sean M.; Peng, Luke; Singh, Shambhavi; Eche-Ugwu, Ijeoma Julie; Gabler, Judith; Fernandez Turizo, Maria J.; Macvicar, Caroline T.; Garg, Aditya; Disciullo, Alexander; Chopra, Kusha; Lenart, Alexandra; Nwodo, Emmanuel; Barnes, Jeffrey; Koh, Min Ji; Miranda, Eliana; Chiattone, Carlos; Stuver, Robert; Horwitz, Steven M.; Merrill, Mwanasha; Jacobsen, Eric; Manni, Martina; Civallero, Monica; Skrypets, Tetiana; Lymboussaki, Athina; Federico, Massimo; Kim, Yuri; Kim, Jin Seok; Cho, Jae Yong; Eipe, Thomas; Shet, Tanuja; Sridhar, Epari; Shetty, Alok; Saha, Saswata; Jain, Hasmukh; Sengar, Manju; Van Der Weyden, Carrie; Prince, Henry Miles; Hamouche, Ramzi; Murdashvili, Tinatin; Foss, Francine; Gentilini, Marianna; Casadei, Beatrice; Zinzani, Pier Luigi; Okatani, Takeshi; Yoshida, Noriaki; Yoon, Sang Eun; Kim, Won-Seog; Panchoo, Girisha; Mohamed, Zainab; Verburgh, Estelle; Alturas, Jackielyn Cuenca; Al-Mansour, Mubarak; Ford, Josie; Cabrera, Maria Elena; Ku, Amy; Bhagat, Govind; Ma, Helen; Sawas, Ahmed; Kariya, Khyati Maulik; Iwasaki, Makoto; Bhanushali, Forum; O'Connor, Owen A.; Marchi, Enrica; Shen, Changyu; Shah, Devavrat; Jain, Salvia
Linfoma diffuso a grandi cellule in seconda linea
2025 Broccoli, Alessandro; Zinzani, PIER LUIGI
Linfoma diffuso a grandi cellule in terza linea (e oltre)
2025 Broccoli, Alessandro; Zinzani, PIER LUIGI
Linfoma mantellare
2025 Broccoli, Alessandro; Zinzani, PIER LUIGI
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study
2025 Hamadani, Mehdi; Caimi, Paolo F.; Hess, Brian; Radford, John; Solh, Melhem; Zinzani, Pier Luigi; Wang, Luqiang; Xu, Zhiying Cindy; Carlo-Stella, Carmelo
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study
2025 Casadei, Beatrice; Argnani, Lisa; Broccoli, Alessandro; Cantelli, Martina; Gugliotta, Gabriele; Gentilini, Marianna; Carella, Matteo; Stefoni, Vittorio; Pellegrini, Cinzia; Fabbri, Nicole; Gabrielli, Giulia; Mazzoni, Camilla; Maglio, Pierluca; Bagnato, Gianmarco; Zinzani, Pier Luigi Luigi
Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed/refractory marginal zone lymphoma
2025 Thieblemont, Catherine; Wahlin, Björn E.; Mohseninejad, Leyla; Wang, Kaijun; Zhang, Ina; Keeping, Sam; Yang, Keri; Zinzani, Pier L.